0
0
1/11/26 at 10:02pm
Organization
STAT
Author
Matthew Herper
31 words
0
Comments
Gene-silencing company Alnylam charts ambitious five-year plan as sales of key drug miss expectations.
You are the first to view
https://www.statnews.com/2026/01/11/alnylam-five-year-plan-amvuttra-investors-jpm-2026/
Create an account
or login to join the discussion